GFAP and Alexander disease: In addition to GFAP mutations, wildtype GFAP overexpression induces the formation of intracellular protein aggregates, thus suggesting that the gene expression level is a modifier element of the disease expressivity [6] and that regulation of GFAP expression may be a pharmacological target in AxD.